Healthcare Industry News: oncolytic virus
News Release - April 24, 2008
AANS/CNS and BrainLAB Announce Winner of 2008 International Research FellowshipWESTCHESTER, Ill., April 24 (HSMN NewsFeed) -- AANS/CNS Section on Tumors and BrainLAB today announced the winner of the 2008 International Research Fellowship. Xiang Wang, MD, from the People's Republic of China, was awarded the fellowship for his proposal, "The Trafficking of Bone Marrow Derived Mesenchymal Stem Cells in Brain Tumor Angiogenesis and Stromal Development."
Dr. Wang will receive a $50,000 stipend to conduct research in his proposed field of study in the laboratory of Victor C-K Tse, MD, PhD, Associate Professor of Neurosurgery at Stanford University. The program will last for one year.
Started in 2006, the fellowship enables international neurosurgeons or graduating residents from outside the United States and Canada to perform clinical, translational or basic research in the field of neurosurgical oncology in a clinical or laboratory setting within the United States. Applications for the 2008 fellowship were received from Brazil, China, Honduras, India, Iran, Italy, Japan, Nigeria and Turkey.
The goal of the fellowship is to foster collaborative research between the U.S. and international neurosurgeons. BrainLAB funds the fellowship through an educational grant and the program receives further support from dedicated U.S. institutions (Investigators), which provide the space and supplies for the applicant during the study period. The winner of the 2007 fellowship, Kazuhiko Kurozumi, MD, from Okayama, Japan, is currently at The Ohio State University laboratory of E. Antonio Chiocca, MD, PhD.
Dr. Kurozumi recently had his paper, "Effect of Tumor Micro-environment Modulation on the Efficacy of oncolytic virus Therapy," published in The Journal of the National Cancer Institute (JNCI 99:1768-81, 2007). His fellowship will be completed in June 2008.
According to Michael McDermott, MD, chairman of the AANS/CNS Section on Tumors, "Partnering with BrainLAB for this fellowship is a valuable contribution to the field of neuro-oncology. We hope to continue this collaborative effort for many years as we work together to make critical advances in the diagnosis and treatment of CNS tumors."
"BrainLAB is pleased to partner again this year with the AANS/CNS Section on Tumors on the International Fellowship," said Paolo Jelmoni, Director of Marketing North America, BrainLAB. "The benefits of collaboration between foreign and domestic medical leaders are infinite. We look forward to Dr. Wang's contributions and are honored to play a part in presenting him with this opportunity."
For more information on the fellowship, application procedures and a list of host institutions, visit http://www.tumorsection.org, or contact the Development Department of AANS at +1 (847) 378-0500 or firstname.lastname@example.org.
Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 7,200 members worldwide. The AANS is dedicated to advancing the specialty of neurological surgery in order to provide the highest quality of neurosurgical care to the public. All active members of the AANS are certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons (Neurosurgery) of Canada or the Mexican Council of Neurological Surgery, AC. Neurosurgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the spinal column, spinal cord, brain and peripheral nerves.
For more information, visit http://www.aans.org.
The Congress of Neurological Surgeons (CNS) is an international neurosurgical association, which has existed since 1951. The purpose of the organization is to enhance health and improve lives worldwide through the advancement of education and scientific exchange. The CNS maintains its vitality via the volunteer efforts of its members, promoting leadership in service to the public and to our colleagues in other disciplines, and to the special needs of our fellow neurosurgeons throughout the world and at every stage of their professional lives.
Members of the CNS include neurosurgeons in-training, board-eligible, and board certified physicians from the United States and other countries. Through active membership, research, advocacy and continuing medical education, the CNS is dedicated to advancing the field of Neurosurgery.
For more information, visit http://www.cns.org.
BrainLAB develops, manufactures and markets software-driven medical technology that enables procedures that are more precise, less invasive, and also less expensive than traditional treatments. Among the core products are image-guided systems that provide highly accurate real-time information used for navigation during surgical procedures. BrainLAB solutions allow expansion from a single system to operating suites to digitally integrated hospitals covering all subspecialties from neurosurgery, orthopedics, ENT, CMF to spine & trauma and oncology.
With more than 3,000 systems installed in over 70 countries, BrainLAB is a market leader in image-guided technology. The privately held BrainLAB group, founded in 1989, is headquartered in Munich, Germany, and today employs 1,000 people in 16 offices across Europe, Asia, Australia, North and South America.
For more information, visit BrainLAB at http://www.brainlab.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.